FDA Enforcement Class II Terminated

VaccZyme Human Anti-Haemophilus influenza type b Enzyme Immunoassay Kit For in vitro diagnostic use, Product Code: MK016 - Product Usage: This assay is designed for the in vitro measurement of specific IgG antibodies against Haemophilus influenzae type b (Hib) capsular polysaccharide, present in human serum. Sufficient materials are supplied to allow a maximum of 41 samples to be tested in duplicate, with a calibration curve and two controls.

Recall: Z-1469-2020 · Reported March 18, 2020

Enforcement

Recall Number
Z-1469-2020
Event ID
84899
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
The Binding Site Group, Ltd.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
March 18, 2020
Initiation Date
August 12, 2018
Classification Date
March 11, 2020
Termination Date
January 20, 2022
Address
8 Calthorpe Road, Birmingham, N/A, United Kingdom

Description

VaccZyme Human Anti-Haemophilus influenza type b Enzyme Immunoassay Kit For in vitro diagnostic use, Product Code: MK016 - Product Usage: This assay is designed for the in vitro measurement of specific IgG antibodies against Haemophilus influenzae type b (Hib) capsular polysaccharide, present in human serum. Sufficient materials are supplied to allow a maximum of 41 samples to be tested in duplicate, with a calibration curve and two controls.

Reason

A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.

Code Info

UDI: 05051700006767. Lot numbers 413170 and 435314.

Distribution

Worldwide distribution - US Nationwide distribution in the states of M.A., C.A., MO., NC, MN, VA, WA, and IL and country of Canada.

Quantity

462 kits